| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.009 | 0.817 | Caspase 9 stimulant | 0.421 0.099 CHEMBL2074871 0.465 0.075 CHEMBL610 | ||
| 0.788 | 0.018 | 0.788 | Apoptosis agonist | 0.425 0.102 CHEMBL3527413 | ||
| 0.765 | 0.005 | 0.765 | Caspase 3 stimulant | |||
| 0.606 | 0.007 | 0.606 | GABA C receptor rho-3 antagonist | 0.475 0.033 CHEMBL2074871 0.529 0.019 CHEMBL610 | ||
| 0.536 | 0.004 | 0.536 | Aldehyde dehydrogenase inhibitor | 0.273 0.015 CHEMBL3527413 0.143 0.052 CHEMBL2074871 0.444 0.005 CHEMBL3526822 0.203 0.027 CHEMBL610 | ||
| 0.537 | 0.022 | 0.847 | 5 Hydroxytryptamine release stimulant | 0.565 0.018 CHEMBL2074871 0.847 0.003 CHEMBL610 | CHEMBL610 | |
| 0.496 | 0.003 | 0.496 | TRPA1 agonist | 0.233 0.006 CHEMBL2074871 0.174 0.018 CHEMBL610 | ||
| 0.483 | 0.023 | 0.609 | Apoptosis antagonist | 0.323 0.071 CHEMBL3527413 0.609 0.009 CHEMBL3526822 0.197 0.183 CHEMBL610 | CHEMBL3526822 | |
| 0.428 | 0.004 | 0.428 | Sigma 1 receptor antagonist | 0.048 0.01 CHEMBL610 | ||
| 0.418 | 0.003 | 0.418 | CYP2A6 inhibitor | 0.156 0.015 CHEMBL2074871 0.333 0.004 CHEMBL610 | ||
| 0.388 | 0.004 | 0.388 | TRPA1 antagonist | 0.141 0.011 CHEMBL2074871 | ||
| 0.381 | 0.004 | 0.381 | Macrophage migration inhibitory factor inhibitor | 0.08 0.052 CHEMBL2074871 0.088 0.043 CHEMBL610 | ||
| 0.365 | 0.022 | 0.532 | 5 Hydroxytryptamine uptake stimulant | 0.393 0.015 CHEMBL2074871 0.532 0.004 CHEMBL610 | CHEMBL610 | |
| 0.366 | 0.03 | 0.366 | Nitric oxide antagonist | |||
| 0.315 | 0.005 | 0.315 | Sigma receptor antagonist | 0.077 0.021 CHEMBL610 | ||
| 0.317 | 0.026 | 0.488 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.111 CHEMBL3527413 0.34 0.018 CHEMBL2074871 0.231 0.089 CHEMBL3526822 0.488 0.004 CHEMBL610 | CHEMBL610 | |
| 0.292 | 0.002 | 0.292 | Vanilloid 2 antagonist | 0.062 0.021 CHEMBL3527413 0.29 0.002 CHEMBL2074871 0.064 0.018 CHEMBL3526822 0.066 0.017 CHEMBL610 | ||
| 0.287 | 0.006 | 0.287 | GABA C receptor rho-2 antagonist | 0.197 0.031 CHEMBL2074871 0.223 0.019 CHEMBL610 | ||
| 0.275 | 0.003 | 0.275 | Adenylate cyclase stimulant | 0.157 0.051 CHEMBL3527413 0.175 0.03 CHEMBL2074871 0.154 0.057 CHEMBL3526822 0.267 0.004 CHEMBL610 | ||
| 0.377 | 0.122 | 0.466 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.407 0.094 CHEMBL2074871 0.466 0.051 CHEMBL610 | CHEMBL610 | |
| 0.316 | 0.064 | 0.404 | Spasmolytic | 0.404 0.039 CHEMBL610 | CHEMBL610 | |
| 0.261 | 0.012 | 0.61 | GABA C receptor agonist | 0.314 0.009 CHEMBL2074871 0.61 0.003 CHEMBL610 | CHEMBL610 | |
| 0.257 | 0.011 | 0.257 | Antibacterial (Helicobacter pylori) | 0.107 0.105 CHEMBL3527413 0.139 0.057 CHEMBL610 | ||
| 0.248 | 0.006 | 0.334 | GABA C receptor antagonist | 0.152 0.029 CHEMBL2074871 0.334 0.004 CHEMBL610 | CHEMBL610 | |
| 0.248 | 0.017 | 0.379 | 5 Hydroxytryptamine 3E antagonist | 0.254 0.014 CHEMBL2074871 0.379 0.003 CHEMBL610 | CHEMBL610 | |
| 0.297 | 0.067 | 0.48 | Aldehyde oxidase inhibitor | 0.265 0.077 CHEMBL2074871 0.48 0.036 CHEMBL610 | CHEMBL610 | |
| 0.272 | 0.043 | 0.723 | Peroxidase inhibitor | 0.723 0.003 CHEMBL3527413 0.22 0.054 CHEMBL2074871 0.585 0.005 CHEMBL3526822 0.437 0.016 CHEMBL610 | CHEMBL3527413 | |
| 0.292 | 0.063 | 0.467 | Insulysin inhibitor | 0.431 0.017 CHEMBL3527413 0.286 0.067 CHEMBL2074871 0.467 0.013 CHEMBL3526822 0.379 0.026 CHEMBL610 | CHEMBL3526822 | |
| 0.305 | 0.077 | 0.666 | Immunostimulant | 0.666 0.01 CHEMBL3527413 0.329 0.07 CHEMBL2074871 0.623 0.014 CHEMBL3526822 0.289 0.082 CHEMBL610 | CHEMBL3527413 | |
| 0.23 | 0.005 | 0.271 | GABA C receptor rho-1 antagonist | 0.145 0.024 CHEMBL2074871 0.271 0.004 CHEMBL610 | CHEMBL610 | |
| 0.253 | 0.03 | 0.318 | Nitric-oxide synthase stimulant | 0.272 0.02 CHEMBL2074871 0.318 0.008 CHEMBL610 | CHEMBL610 | |
| 0.27 | 0.063 | 0.542 | Superoxide dismutase inhibitor | 0.409 0.025 CHEMBL3527413 0.254 0.072 CHEMBL2074871 0.229 0.09 CHEMBL3526822 0.542 0.01 CHEMBL610 | CHEMBL610 | |
| 0.255 | 0.048 | 0.375 | Anesthetic general | 0.175 0.09 CHEMBL2074871 0.375 0.02 CHEMBL610 | CHEMBL610 | |
| 0.333 | 0.13 | 0.516 | 5 Hydroxytryptamine release inhibitor | 0.374 0.096 CHEMBL2074871 0.516 0.027 CHEMBL610 | CHEMBL610 | |
| 0.211 | 0.01 | 0.211 | Hedgehog signaling inhibitor | |||
| 0.291 | 0.101 | 0.422 | Calcium channel activator | 0.32 0.073 CHEMBL2074871 0.422 0.017 CHEMBL610 | CHEMBL610 | |
| 0.187 | 0.012 | 0.187 | Opioid kappa receptor antagonist | 0.087 0.049 CHEMBL610 | ||
| 0.182 | 0.01 | 0.261 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CHEMBL3527413 0.109 0.03 CHEMBL3526822 0.261 0.005 CHEMBL610 | CHEMBL610 | |
| 0.174 | 0.003 | 0.174 | Exportin-1 inhibitor | 0.08 0.025 CHEMBL2074871 0.103 0.008 CHEMBL610 | ||
| 0.194 | 0.024 | 0.347 | Ferrochelatase inhibitor | 0.238 0.015 CHEMBL2074871 0.347 0.005 CHEMBL610 | CHEMBL610 | |
| 0.201 | 0.034 | 0.295 | Alpha-N-acetylglucosaminidase inhibitor | 0.241 0.024 CHEMBL2074871 0.295 0.017 CHEMBL610 | CHEMBL610 | |
| 0.174 | 0.009 | 0.5 | Phenylalanine 4-hydroxylase inhibitor | 0.3 0.004 CHEMBL3527413 0.163 0.01 CHEMBL2074871 0.154 0.011 CHEMBL3526822 0.5 0.002 CHEMBL610 | CHEMBL610 | |
| 0.176 | 0.015 | 0.282 | Nitric-oxide synthase inhibitor | 0.156 0.02 CHEMBL3527413 0.144 0.025 CHEMBL3526822 0.282 0.005 CHEMBL610 | CHEMBL610 | |
| 0.166 | 0.007 | 0.199 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.034 CHEMBL2074871 0.199 0.004 CHEMBL610 | CHEMBL610 | |
| 0.242 | 0.088 | 0.285 | Antioxidant | 0.285 0.068 CHEMBL3527413 0.255 0.081 CHEMBL3526822 | CHEMBL3527413 | |
| 0.165 | 0.012 | 0.165 | Cannabinoid receptor antagonist | |||
| 0.264 | 0.118 | 0.332 | Transcription factor NF kappa B inhibitor | 0.291 0.1 CHEMBL3527413 0.301 0.093 CHEMBL3526822 0.332 0.082 CHEMBL610 | CHEMBL610 | |
| 0.236 | 0.09 | 0.372 | 5 Hydroxytryptamine 1E antagonist | 0.254 0.07 CHEMBL2074871 0.372 0.007 CHEMBL610 | CHEMBL610 | |
| 0.16 | 0.018 | 0.321 | Porphobilinogen synthase inhibitor | 0.152 0.02 CHEMBL2074871 0.321 0.005 CHEMBL610 | CHEMBL610 | |
| 0.158 | 0.018 | 0.158 | Opioid delta receptor antagonist | 0.087 0.034 CHEMBL610 | ||
| 0.244 | 0.113 | 0.244 | 12-Lipoxygenase inhibitor | 0.183 0.17 CHEMBL2074871 0.2 0.152 CHEMBL610 | ||
| 0.137 | 0.009 | 0.137 | Cannabinoid CB1 receptor antagonist | |||
| 0.152 | 0.025 | 0.152 | Opioid antagonist | 0.077 0.073 CHEMBL3527413 0.122 0.035 CHEMBL610 | ||
| 0.23 | 0.105 | 0.275 | Gastrin inhibitor | 0.246 0.084 CHEMBL3527413 0.225 0.111 CHEMBL2074871 0.246 0.084 CHEMBL3526822 0.275 0.053 CHEMBL610 | CHEMBL610 | |
| 0.141 | 0.017 | 0.316 | Histamine N-methyltransferase inhibitor | 0.138 0.019 CHEMBL2074871 0.316 0.003 CHEMBL610 | CHEMBL610 | |
| 0.192 | 0.078 | 0.192 | Non-steroidal antiinflammatory agent | 0.181 0.087 CHEMBL610 | ||
| 0.214 | 0.101 | 0.267 | Calpain inhibitor | 0.267 0.051 CHEMBL3527413 0.214 0.101 CHEMBL2074871 0.261 0.055 CHEMBL3526822 0.263 0.054 CHEMBL610 | CHEMBL3527413 | |
| 0.134 | 0.021 | 0.134 | Opioid mu receptor antagonist | 0.094 0.034 CHEMBL610 | ||
| 0.284 | 0.171 | 0.471 | Calcium channel L-type activator | 0.358 0.111 CHEMBL2074871 0.471 0.04 CHEMBL610 | CHEMBL610 | |
| 0.256 | 0.146 | 0.294 | Calpain 2 inhibitor | 0.25 0.149 CHEMBL3527413 0.236 0.16 CHEMBL2074871 0.215 0.175 CHEMBL3526822 0.294 0.118 CHEMBL610 | CHEMBL610 | |
| 0.148 | 0.039 | 0.417 | Aminopeptidase B inhibitor | 0.411 0.004 CHEMBL3527413 0.153 0.036 CHEMBL2074871 0.417 0.004 CHEMBL3526822 0.242 0.014 CHEMBL610 | CHEMBL3526822 | |
| 0.136 | 0.028 | 0.158 | Acetylcholine release stimulant | 0.138 0.025 CHEMBL2074871 0.158 0.012 CHEMBL610 | CHEMBL610 | |
| 0.127 | 0.019 | 0.572 | Glutamate decarboxylase inhibitor | 0.572 0.002 CHEMBL3527413 0.123 0.02 CHEMBL2074871 0.514 0.002 CHEMBL3526822 0.319 0.003 CHEMBL610 | CHEMBL3527413 | |
| 0.151 | 0.044 | 0.269 | Adenylate cyclase inhibitor | 0.269 0.017 CHEMBL610 | CHEMBL610 | |
| 0.114 | 0.013 | 0.137 | Estrogen-related receptor beta agonist | 0.121 0.009 CHEMBL2074871 0.137 0.005 CHEMBL610 | CHEMBL610 | |
| 0.141 | 0.041 | 0.305 | 5 Hydroxytryptamine 3A agonist | 0.161 0.03 CHEMBL2074871 0.305 0.003 CHEMBL610 | CHEMBL610 | |
| 0.157 | 0.059 | 0.192 | Cell wall synthesis inhibitor | 0.146 0.07 CHEMBL3527413 0.192 0.033 CHEMBL610 | CHEMBL610 | |
| 0.147 | 0.05 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.152 0.039 CHEMBL2074871 0.16 0.024 CHEMBL610 | CHEMBL610 | |
| 0.108 | 0.013 | 0.108 | Cannabinoid CB2 receptor antagonist | |||
| 0.106 | 0.017 | 0.106 | Dopamine uptake inhibitor | 0.091 0.021 CHEMBL610 | ||
| 0.168 | 0.082 | 0.234 | Succinate dehydrogenase inhibitor | 0.187 0.061 CHEMBL2074871 0.234 0.029 CHEMBL610 | CHEMBL610 | |
| 0.133 | 0.047 | 0.133 | MAO A inhibitor | 0.1 0.064 CHEMBL610 | ||
| 0.191 | 0.105 | 0.197 | Free radical scavenger | 0.197 0.1 CHEMBL3527413 0.168 0.125 CHEMBL3526822 | CHEMBL3527413 | |
| 0.09 | 0.005 | 0.09 | Sigma 2 receptor antagonist | 0.035 0.014 CHEMBL610 | ||
| 0.161 | 0.076 | 0.18 | Arachidonic acid antagonist | 0.164 0.072 CHEMBL2074871 0.18 0.054 CHEMBL610 | CHEMBL610 | |
| 0.124 | 0.041 | 0.177 | DOPA decarboxylase inhibitor | 0.135 0.031 CHEMBL2074871 0.177 0.011 CHEMBL610 | CHEMBL610 | |
| 0.084 | 0.004 | 0.084 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.105 | 0.025 | 0.228 | Aminopeptidase I inhibitor | 0.212 0.006 CHEMBL3527413 0.117 0.02 CHEMBL2074871 0.228 0.005 CHEMBL3526822 0.174 0.009 CHEMBL610 | CHEMBL3526822 | |
| 0.115 | 0.035 | 0.169 | Triose-phosphate isomerase inhibitor | 0.118 0.034 CHEMBL2074871 0.169 0.015 CHEMBL610 | CHEMBL610 | |
| 0.118 | 0.039 | 0.202 | Prolactin inhibitor | 0.132 0.031 CHEMBL2074871 0.202 0.008 CHEMBL610 | CHEMBL610 | |
| 0.094 | 0.018 | 0.136 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.089 0.024 CHEMBL2074871 0.136 0.004 CHEMBL610 | CHEMBL610 | |
| 0.198 | 0.123 | 0.344 | Interleukin agonist | 0.245 0.082 CHEMBL3527413 0.19 0.13 CHEMBL2074871 0.233 0.092 CHEMBL3526822 0.344 0.031 CHEMBL610 | CHEMBL610 | |
| 0.104 | 0.03 | 0.187 | NMDA 2 receptor antagonist | 0.187 0.011 CHEMBL610 | CHEMBL610 | |
| 0.079 | 0.005 | 0.079 | Benzodiazepine antagonist | |||
| 0.174 | 0.102 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.173 0.103 CHEMBL2074871 0.314 0.019 CHEMBL610 | CHEMBL610 | |
| 0.088 | 0.017 | 0.097 | Glutamate (mGluR6) antagonist | 0.067 0.047 CHEMBL2074871 0.097 0.012 CHEMBL610 | CHEMBL610 | |
| 0.106 | 0.038 | 0.143 | NADH dehydrogenase inhibitor | 0.117 0.03 CHEMBL2074871 0.143 0.019 CHEMBL610 | CHEMBL610 | |
| 0.114 | 0.046 | 0.197 | Sphingomyelinase inhibitor | 0.121 0.04 CHEMBL2074871 0.197 0.01 CHEMBL610 | CHEMBL610 | |
| 0.102 | 0.033 | 0.22 | Myeloperoxidase inhibitor | 0.22 0.005 CHEMBL610 | CHEMBL610 | |
| 0.097 | 0.028 | 0.097 | Carbonic anhydrase inhibitor | 0.084 0.033 CHEMBL3527413 0.095 0.029 CHEMBL2074871 0.064 0.044 CHEMBL610 | ||
| 0.075 | 0.007 | 0.233 | Dopamine D5 agonist | 0.077 0.007 CHEMBL2074871 0.233 0.002 CHEMBL610 | CHEMBL610 | |
| 0.116 | 0.049 | 0.123 | Urease inhibitor | 0.123 0.043 CHEMBL610 | CHEMBL610 | |
| 0.114 | 0.049 | 0.193 | Adenylate kinase inhibitor | 0.11 0.053 CHEMBL3527413 0.128 0.037 CHEMBL2074871 0.121 0.043 CHEMBL3526822 0.193 0.016 CHEMBL610 | CHEMBL610 | |
| 0.224 | 0.16 | 0.386 | Vasodilator, coronary | 0.259 0.125 CHEMBL2074871 0.386 0.04 CHEMBL610 | CHEMBL610 | |
| 0.073 | 0.009 | 0.094 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 CHEMBL2074871 0.094 0.004 CHEMBL610 | CHEMBL610 | |
| 0.154 | 0.092 | 0.24 | Neurotensin receptor agonist | 0.222 0.027 CHEMBL3527413 0.159 0.08 CHEMBL2074871 0.223 0.026 CHEMBL3526822 0.24 0.023 CHEMBL610 | CHEMBL610 | |
| 0.111 | 0.05 | 0.156 | UDP-glucose 4-epimerase inhibitor | 0.129 0.038 CHEMBL2074871 0.156 0.027 CHEMBL610 | CHEMBL610 | |
| 0.071 | 0.01 | 0.115 | Histamine H2 receptor agonist | 0.073 0.009 CHEMBL2074871 0.115 0.003 CHEMBL610 | CHEMBL610 | |
| 0.129 | 0.069 | 0.174 | Vanilloid 1 agonist | 0.169 0.024 CHEMBL3527413 0.126 0.073 CHEMBL2074871 0.174 0.021 CHEMBL3526822 0.173 0.021 CHEMBL610 | CHEMBL3526822 | |
| 0.247 | 0.188 | 0.247 | Transcription factor inhibitor | |||
| 0.192 | 0.134 | 0.27 | Neuropeptide Y2 antagonist | 0.181 0.157 CHEMBL3527413 0.18 0.159 CHEMBL2074871 0.183 0.153 CHEMBL3526822 0.27 0.038 CHEMBL610 | CHEMBL610 | |
| 0.128 | 0.069 | 0.194 | Cyclooxygenase 3 inhibitor | 0.151 0.048 CHEMBL3527413 0.13 0.067 CHEMBL2074871 0.168 0.034 CHEMBL3526822 0.194 0.021 CHEMBL610 | CHEMBL610 | |
| 0.168 | 0.112 | 0.242 | Neurotrophic factor enhancer | 0.188 0.088 CHEMBL2074871 0.242 0.043 CHEMBL610 | CHEMBL610 | |
| 0.08 | 0.024 | 0.283 | Alcohol oxidase inhibitor | 0.076 0.026 CHEMBL2074871 0.283 0.005 CHEMBL610 | CHEMBL610 | |
| 0.107 | 0.052 | 0.183 | Creatine kinase inhibitor | 0.121 0.04 CHEMBL2074871 0.183 0.014 CHEMBL610 | CHEMBL610 | |
| 0.087 | 0.032 | 0.166 | Carbonic anhydrase VA inhibitor | 0.063 0.056 CHEMBL2074871 0.166 0.008 CHEMBL610 | CHEMBL610 | |
| 0.107 | 0.055 | 0.224 | Carbonic anhydrase III inhibitor | 0.098 0.065 CHEMBL2074871 0.224 0.013 CHEMBL610 | CHEMBL610 | |
| 0.063 | 0.012 | 0.139 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 CHEMBL2074871 0.139 0.003 CHEMBL610 | CHEMBL610 | |
| 0.058 | 0.009 | 0.058 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 CHEMBL610 | ||
| 0.078 | 0.029 | 0.078 | Cannabinoid CB1 receptor agonist | |||
| 0.067 | 0.02 | 0.117 | Epithelial sodium channel blocker | 0.074 0.015 CHEMBL2074871 0.117 0.005 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.017 | 0.076 | Carbonic anhydrase IV inhibitor | 0.058 0.02 CHEMBL3527413 0.076 0.012 CHEMBL610 | CHEMBL610 | |
| 0.086 | 0.039 | 0.238 | GABA aminotransferase inhibitor | 0.1 0.027 CHEMBL2074871 0.238 0.004 CHEMBL610 | CHEMBL610 | |
| 0.121 | 0.074 | 0.212 | Cathepsin H inhibitor | 0.135 0.058 CHEMBL2074871 0.212 0.019 CHEMBL610 | CHEMBL610 | |
| 0.106 | 0.06 | 0.372 | Carbonic anhydrase XV inhibitor | 0.12 0.047 CHEMBL2074871 0.372 0.005 CHEMBL610 | CHEMBL610 | |
| 0.141 | 0.095 | 0.175 | Melanin inhibitor | 0.136 0.104 CHEMBL2074871 0.175 0.055 CHEMBL610 | CHEMBL610 | |
| 0.08 | 0.035 | 0.185 | Carbonic anhydrase V inhibitor | 0.185 0.009 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.022 | 0.109 | Aconitate hydratase inhibitor | 0.078 0.015 CHEMBL2074871 0.109 0.007 CHEMBL610 | CHEMBL610 | |
| 0.098 | 0.056 | 0.209 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.13 0.034 CHEMBL3527413 0.117 0.041 CHEMBL2074871 0.151 0.026 CHEMBL3526822 0.209 0.014 CHEMBL610 | CHEMBL610 | |
| 0.071 | 0.029 | 0.071 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.051 | 0.01 | 0.051 | Purinergic P2Y2 antagonist | |||
| 0.135 | 0.094 | 0.169 | Heat shock protein 70 antagonist | 0.132 0.109 CHEMBL2074871 0.169 0.018 CHEMBL610 | CHEMBL610 | |
| 0.122 | 0.081 | 0.249 | Nav1.2 sodium channel blocker | 0.14 0.063 CHEMBL2074871 0.249 0.022 CHEMBL610 | CHEMBL610 | |
| 0.103 | 0.063 | 0.141 | Alpha 2c adrenoreceptor antagonist | 0.141 0.037 CHEMBL610 | CHEMBL610 | |
| 0.117 | 0.078 | 0.121 | DNA repair enzyme inhibitor | 0.121 0.069 CHEMBL610 | CHEMBL610 | |
| 0.053 | 0.014 | 0.096 | Histamine H1 receptor agonist | 0.055 0.012 CHEMBL2074871 0.096 0.003 CHEMBL610 | CHEMBL610 | |
| 0.067 | 0.028 | 0.076 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 CHEMBL2074871 0.076 0.022 CHEMBL610 | CHEMBL610 | |
| 0.124 | 0.086 | 0.179 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.063 CHEMBL2074871 0.179 0.015 CHEMBL610 | CHEMBL610 | |
| 0.101 | 0.063 | 0.113 | Bronchodilator | 0.113 0.049 CHEMBL610 | CHEMBL610 | |
| 0.069 | 0.033 | 0.149 | Biliverdin reductase inhibitor | 0.085 0.024 CHEMBL2074871 0.149 0.009 CHEMBL610 | CHEMBL610 | |
| 0.089 | 0.053 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.039 CHEMBL2074871 0.116 0.019 CHEMBL610 | CHEMBL610 | |
| 0.103 | 0.067 | 0.183 | Falcipain 3 inhibitor | 0.124 0.051 CHEMBL2074871 0.183 0.023 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.029 | 0.128 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 CHEMBL2074871 0.128 0.011 CHEMBL610 | CHEMBL610 | |
| 0.068 | 0.032 | 0.091 | Calcium channel P-type blocker | 0.071 0.026 CHEMBL2074871 0.091 0.008 CHEMBL610 | CHEMBL610 | |
| 0.056 | 0.021 | 0.105 | Adenylate cyclase 1 inhibitor | 0.068 0.013 CHEMBL2074871 0.105 0.004 CHEMBL610 | CHEMBL610 | |
| 0.176 | 0.141 | 0.222 | RNA-directed DNA polymerase inhibitor | 0.165 0.162 CHEMBL2074871 0.222 0.072 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.032 | 0.091 | Carbonic anhydrase I inhibitor | 0.091 0.021 CHEMBL3527413 0.086 0.022 CHEMBL2074871 0.065 0.031 CHEMBL610 | CHEMBL3527413 | |
| 0.088 | 0.056 | 0.238 | NMDA receptor antagonist | 0.238 0.01 CHEMBL610 | CHEMBL610 | |
| 0.083 | 0.052 | 0.113 | Glycine receptor antagonist | 0.089 0.044 CHEMBL2074871 0.113 0.022 CHEMBL610 | CHEMBL610 | |
| 0.146 | 0.115 | 0.535 | Phospholipase C inhibitor | 0.535 0.005 CHEMBL3527413 0.141 0.127 CHEMBL2074871 0.441 0.008 CHEMBL3526822 0.354 0.014 CHEMBL610 | CHEMBL3527413 | |
| 0.063 | 0.033 | 0.072 | Carbonic anhydrase II inhibitor | 0.072 0.029 CHEMBL3527413 0.06 0.035 CHEMBL610 | CHEMBL3527413 | |
| 0.065 | 0.035 | 0.161 | Carbonic anhydrase stimulant | 0.125 0.014 CHEMBL3527413 0.074 0.029 CHEMBL2074871 0.111 0.016 CHEMBL3526822 0.161 0.01 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | 0.041 0.028 CHEMBL610 | ||
| 0.063 | 0.037 | 0.083 | Beta 2 adrenoreceptor agonist | 0.059 0.052 CHEMBL2074871 0.083 0.008 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.018 | 0.222 | Diamine oxidase inhibitor | 0.051 0.014 CHEMBL2074871 0.222 0.003 CHEMBL610 | CHEMBL610 | |
| 0.091 | 0.065 | 0.166 | MAO B inhibitor | 0.166 0.032 CHEMBL610 | CHEMBL610 | |
| 0.105 | 0.079 | 0.176 | Photosensitizer | 0.117 0.061 CHEMBL2074871 0.176 0.019 CHEMBL610 | CHEMBL610 | |
| 0.095 | 0.069 | 0.095 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.057 | 0.031 | 0.168 | NMDA 2A receptor antagonist | 0.067 0.026 CHEMBL3527413 0.074 0.023 CHEMBL3526822 0.168 0.005 CHEMBL610 | CHEMBL610 | |
| 0.046 | 0.021 | 0.05 | Heme oxygenase inhibitor | 0.048 0.017 CHEMBL2074871 0.05 0.013 CHEMBL610 | CHEMBL610 | |
| 0.039 | 0.015 | 0.049 | Melatonin receptor 1A agonist | 0.037 0.018 CHEMBL2074871 0.049 0.008 CHEMBL610 | CHEMBL610 | |
| 0.071 | 0.047 | 0.136 | Phosphofructokinase-1 inhibitor | 0.087 0.037 CHEMBL2074871 0.136 0.021 CHEMBL610 | CHEMBL610 | |
| 0.1 | 0.076 | 0.166 | Cystathionine beta-synthase inhibitor | 0.12 0.058 CHEMBL2074871 0.166 0.034 CHEMBL610 | CHEMBL610 | |
| 0.064 | 0.04 | 0.152 | NMDA 2C receptor antagonist | 0.152 0.007 CHEMBL610 | CHEMBL610 | |
| 0.057 | 0.034 | 0.057 | GABA receptor antagonist | |||
| 0.063 | 0.04 | 0.088 | Purinergic P2X1 antagonist | 0.072 0.03 CHEMBL2074871 0.088 0.021 CHEMBL610 | CHEMBL610 | |
| 0.074 | 0.051 | 0.177 | Glutamate dehydrogenase inhibitor | 0.15 0.016 CHEMBL3527413 0.086 0.039 CHEMBL2074871 0.169 0.013 CHEMBL3526822 0.177 0.012 CHEMBL610 | CHEMBL610 | |
| 0.081 | 0.06 | 0.101 | CC chemokine 5 receptor agonist | 0.086 0.045 CHEMBL2074871 0.101 0.02 CHEMBL610 | CHEMBL610 | |
| 0.055 | 0.034 | 0.055 | GABA A receptor antagonist | |||
| 0.038 | 0.019 | 0.054 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 CHEMBL2074871 0.054 0.004 CHEMBL610 | CHEMBL610 | |
| 0.046 | 0.026 | 0.063 | Glutamate (mGluR group III) antagonist | 0.063 0.012 CHEMBL610 | CHEMBL610 | |
| 0.042 | 0.024 | 0.065 | Membrane dipeptidase inhibitor | 0.065 0.008 CHEMBL3527413 0.059 0.01 CHEMBL3526822 0.047 0.018 CHEMBL610 | CHEMBL3527413 | |
| 0.086 | 0.069 | 0.195 | HIV-1 integrase (Overall Integration) inhibitor | 0.102 0.053 CHEMBL2074871 0.195 0.013 CHEMBL610 | CHEMBL610 | |
| 0.056 | 0.039 | 0.2 | Carbonic anhydrase VB inhibitor | 0.053 0.042 CHEMBL2074871 0.2 0.005 CHEMBL610 | CHEMBL610 | |
| 0.077 | 0.061 | 0.271 | Carbonic anhydrase VI inhibitor | 0.073 0.067 CHEMBL2074871 0.271 0.007 CHEMBL610 | CHEMBL610 | |
| 0.091 | 0.076 | 0.123 | Anabolic | 0.1 0.062 CHEMBL2074871 0.123 0.037 CHEMBL610 | CHEMBL610 | |
| 0.028 | 0.013 | 0.039 | Acid ceramidase inhibitor | 0.031 0.008 CHEMBL2074871 0.039 0.004 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.05 | 0.073 | Potassium channel (ATP-sensitive) blocker | 0.061 0.058 CHEMBL2074871 0.073 0.037 CHEMBL610 | CHEMBL610 | |
| 0.044 | 0.03 | 0.077 | Geranyltranstransferase inhibitor | 0.048 0.025 CHEMBL2074871 0.077 0.005 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.046 | 0.23 | 5 Hydroxytryptamine 2A agonist | 0.069 0.037 CHEMBL2074871 0.23 0.004 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.011 | 0.065 | Imidazoline I1 receptor antagonist | 0.065 0.003 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.03 | 0.048 | Guanylate cyclase inhibitor | 0.048 0.023 CHEMBL610 | CHEMBL610 | |
| 0.058 | 0.045 | 0.116 | Carbamoyl phosphate synthetase inhibitor | 0.069 0.036 CHEMBL2074871 0.055 0.049 CHEMBL3526822 0.116 0.016 CHEMBL610 | CHEMBL610 | |
| 0.08 | 0.067 | 0.141 | Alpha 2 adrenoreceptor antagonist | 0.141 0.03 CHEMBL610 | CHEMBL610 | |
| 0.119 | 0.106 | 0.197 | Diuretic | 0.197 0.045 CHEMBL610 | CHEMBL610 | |
| 0.148 | 0.136 | 0.336 | Insulin sensitizer | 0.336 0.01 CHEMBL3527413 0.155 0.126 CHEMBL2074871 0.305 0.015 CHEMBL3526822 0.235 0.044 CHEMBL610 | CHEMBL3527413 | |
| 0.101 | 0.089 | 0.216 | MAO inhibitor | 0.216 0.036 CHEMBL610 | CHEMBL610 | |
| 0.077 | 0.066 | 0.168 | Calcium antagonist | 0.089 0.056 CHEMBL2074871 0.168 0.018 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.008 | 0.02 | Adenosine A2a receptor agonist | 0.016 0.01 CHEMBL610 | ||
| 0.062 | 0.051 | 0.078 | Histone deacetylase inhibitor | 0.078 0.032 CHEMBL3527413 0.075 0.035 CHEMBL3526822 0.062 0.051 CHEMBL610 | CHEMBL3527413 | |
| 0.026 | 0.016 | 0.037 | Vanilloid 2 agonist | 0.028 0.013 CHEMBL2074871 0.037 0.005 CHEMBL610 | CHEMBL610 | |
| 0.099 | 0.089 | 0.121 | Cholesterol synthesis inhibitor | 0.111 0.074 CHEMBL2074871 0.121 0.064 CHEMBL610 | CHEMBL610 | |
| 0.051 | 0.041 | 0.081 | Alpha-mannosidase inhibitor | 0.055 0.034 CHEMBL2074871 0.081 0.011 CHEMBL610 | CHEMBL610 | |
| 0.046 | 0.036 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.029 CHEMBL2074871 0.054 0.024 CHEMBL610 | CHEMBL610 | |
| 0.042 | 0.033 | 0.061 | AICAR transformylase inhibitor | 0.05 0.022 CHEMBL3527413 0.044 0.03 CHEMBL2074871 0.052 0.02 CHEMBL3526822 0.061 0.014 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.05 | 0.099 | Histone deacetylase SIRT3 inhibitor | 0.06 0.05 CHEMBL3527413 0.099 0.01 CHEMBL610 | CHEMBL610 | |
| 0.068 | 0.059 | 0.115 | Alpha 2a adrenoreceptor antagonist | 0.115 0.03 CHEMBL610 | CHEMBL610 | |
| 0.058 | 0.049 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.088 | 0.079 | 0.141 | Electrolyte absorption antagonist | 0.099 0.059 CHEMBL2074871 0.141 0.023 CHEMBL610 | CHEMBL610 | |
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 CHEMBL610 | ||
| 0.042 | 0.034 | 0.05 | Dihydrofolate reductase inhibitor | 0.05 0.018 CHEMBL610 | CHEMBL610 | |
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | 0.016 0.011 CHEMBL610 | ||
| 0.039 | 0.032 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.074 | 0.067 | 0.102 | MAP kinase kinase 7 inhibitor | 0.075 0.064 CHEMBL2074871 0.102 0.011 CHEMBL610 | CHEMBL610 | |
| 0.084 | 0.077 | 0.125 | Glutamate release inhibitor | 0.125 0.019 CHEMBL610 | CHEMBL610 | |
| 0.185 | 0.179 | 0.316 | Cholesterol antagonist | 0.227 0.142 CHEMBL2074871 0.316 0.081 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.055 | 0.089 | Beta 3 adrenoreceptor antagonist | 0.062 0.049 CHEMBL2074871 0.089 0.018 CHEMBL610 | CHEMBL610 | |
| 0.063 | 0.057 | 0.098 | Glutamate (mGluR7) antagonist | 0.072 0.039 CHEMBL2074871 0.098 0.012 CHEMBL610 | CHEMBL610 | |
| 0.087 | 0.082 | 0.087 | Gastric antisecretory | |||
| 0.014 | 0.009 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 CHEMBL2074871 0.016 0.005 CHEMBL610 | CHEMBL610 | |
| 0.031 | 0.027 | 0.061 | Fumarate hydratase inhibitor | 0.038 0.02 CHEMBL2074871 0.061 0.01 CHEMBL610 | CHEMBL610 | |
| 0.215 | 0.212 | 0.312 | Antibacterial | 0.296 0.138 CHEMBL3527413 0.312 0.126 CHEMBL610 | CHEMBL610 | |
| 0.05 | 0.047 | 0.128 | Argininosuccinate synthase inhibitor | 0.062 0.035 CHEMBL2074871 0.128 0.014 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.015 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CHEMBL610 | CHEMBL610 | |
| 0.078 | 0.075 | 0.097 | D-Ala-D-Ala ligase inhibitor | 0.097 0.034 CHEMBL610 | CHEMBL610 | |
| 0.046 | 0.043 | 0.056 | Squalene epoxidase inhibitor | 0.056 0.024 CHEMBL610 | CHEMBL610 | |
| 0.035 | 0.033 | 0.061 | Glutamate (mGluR8) agonist | 0.039 0.025 CHEMBL2074871 0.037 0.029 CHEMBL3526822 0.061 0.007 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.023 | 0.117 | 5 Hydroxytryptamine 1D agonist | 0.028 0.02 CHEMBL2074871 0.117 0.004 CHEMBL610 | CHEMBL610 | |
| 0.017 | 0.016 | 0.026 | Estrogen-related receptor gamma agonist | 0.019 0.012 CHEMBL2074871 0.026 0.005 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.022 | 0.033 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 CHEMBL2074871 0.033 0.009 CHEMBL610 | CHEMBL610 | |
| 0.031 | 0.03 | 0.078 | Phosphoglycerate kinase inhibitor | 0.034 0.026 CHEMBL2074871 0.078 0.009 CHEMBL610 | CHEMBL610 | |
| 0.038 | 0.037 | 0.064 | NMDA receptor subunit 3B antagonist | 0.064 0.018 CHEMBL610 | CHEMBL610 | |
| 0.069 | 0.068 | 0.084 | Vanilloid 4 agonist | 0.075 0.052 CHEMBL2074871 0.084 0.034 CHEMBL610 | CHEMBL610 | |
| 0.049 | 0.049 | 0.106 | Sphingosine kinase 2 inhibitor | 0.052 0.043 CHEMBL2074871 0.106 0.006 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.036 | 0.064 | Oxytocin agonist | 0.052 0.022 CHEMBL3527413 0.038 0.034 CHEMBL2074871 0.054 0.021 CHEMBL3526822 0.064 0.014 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.04 | 0.082 | Mannosidase inhibitor | 0.044 0.033 CHEMBL2074871 0.082 0.008 CHEMBL610 | CHEMBL610 | |
| 0.034 | 0.035 | 0.077 | Alpha 1d adrenoreceptor agonist | 0.077 0.005 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.021 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 CHEMBL610 | CHEMBL610 | |
| 0.121 | 0.123 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.091 CHEMBL2074871 0.183 0.022 CHEMBL610 | CHEMBL610 | |
| 0.034 | 0.036 | 0.062 | Dihydropteroate synthase inhibitor | 0.039 0.028 CHEMBL2074871 0.062 0.011 CHEMBL610 | CHEMBL610 | |
| 0.101 | 0.104 | 0.189 | Transcription factor STAT6 inhibitor | 0.113 0.075 CHEMBL2074871 0.189 0.008 CHEMBL610 | CHEMBL610 | |
| 0.064 | 0.067 | 0.088 | Phospholipase D inhibitor | 0.072 0.048 CHEMBL2074871 0.088 0.024 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.063 | 0.419 | Histidine decarboxylase inhibitor | 0.384 0.004 CHEMBL3527413 0.075 0.047 CHEMBL2074871 0.419 0.004 CHEMBL3526822 0.339 0.005 CHEMBL610 | CHEMBL3526822 | |
| 0.057 | 0.06 | 0.177 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 CHEMBL3527413 0.061 0.05 CHEMBL2074871 0.177 0.005 CHEMBL3526822 0.097 0.017 CHEMBL610 | CHEMBL3526822 | |
| 0.088 | 0.091 | 0.133 | Glutamate (mGluR7) agonist | 0.097 0.065 CHEMBL2074871 0.133 0.02 CHEMBL610 | CHEMBL610 | |
| 0.037 | 0.041 | 0.059 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 CHEMBL2074871 0.059 0.008 CHEMBL610 | CHEMBL610 | |
| 0.069 | 0.073 | 0.141 | GABA B receptor agonist | 0.076 0.051 CHEMBL2074871 0.141 0.005 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.049 | 0.14 | Histamine agonist | 0.084 0.013 CHEMBL2074871 0.14 0.005 CHEMBL610 | CHEMBL610 | |
| 0.054 | 0.06 | 0.066 | Ryanodine receptor antagonist | 0.066 0.024 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.031 | 0.04 | Purinergic P2Y15 antagonist | 0.027 0.024 CHEMBL2074871 0.04 0.007 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.012 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.026 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.026 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 CHEMBL610 | CHEMBL610 | |
| 0.03 | 0.038 | 0.106 | Carbonic anhydrase I stimulant | 0.06 0.012 CHEMBL3527413 0.034 0.031 CHEMBL2074871 0.057 0.013 CHEMBL3526822 0.106 0.004 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.026 | 0.027 | Prostaglandin H2 antagonist | 0.023 0.02 CHEMBL2074871 0.027 0.016 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.024 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.012 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.034 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.012 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.045 | 0.061 | Kainate receptor agonist | 0.04 0.032 CHEMBL2074871 0.061 0.006 CHEMBL610 | CHEMBL610 | |
| 0.116 | 0.126 | 0.267 | Thiol protease inhibitor | 0.267 0.023 CHEMBL3527413 0.25 0.026 CHEMBL3526822 0.208 0.037 CHEMBL610 | CHEMBL3527413 | |
| 0.021 | 0.032 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 CHEMBL2074871 0.03 0.014 CHEMBL610 | CHEMBL610 | |
| 0.053 | 0.064 | 0.147 | 5 Hydroxytryptamine 3 agonist | 0.057 0.053 CHEMBL2074871 0.147 0.005 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.035 | 0.057 | 5 Hydroxytryptamine 6 agonist | 0.057 0.004 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.051 | 0.117 | Ornithine carbamoyltransferase inhibitor | 0.103 0.015 CHEMBL3527413 0.048 0.042 CHEMBL2074871 0.117 0.013 CHEMBL3526822 0.113 0.014 CHEMBL610 | CHEMBL3526822 | |
| 0.072 | 0.084 | 0.157 | Histamine H2 receptor antagonist | 0.157 0.009 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.032 | 0.054 | Lysine carboxypeptidase inhibitor | 0.047 0.008 CHEMBL3527413 0.054 0.007 CHEMBL3526822 0.05 0.008 CHEMBL610 | CHEMBL3526822 | |
| 0.031 | 0.044 | 0.063 | GABA uptake inhibitor | 0.036 0.033 CHEMBL2074871 0.063 0.009 CHEMBL610 | CHEMBL610 | |
| 0.007 | 0.021 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.005 CHEMBL610 | CHEMBL610 | |
| 0.058 | 0.072 | 0.218 | Carbonic anhydrase XIII inhibitor | 0.086 0.046 CHEMBL2074871 0.218 0.012 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.037 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.037 | 0.033 | Complement factor 1s inhibitor | 0.033 0.005 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.081 | 0.159 | Adrenaline agonist | 0.159 0.013 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.038 | 0.088 | Endothelial nitric-oxide synthase inhibitor | 0.088 0.005 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.025 | 0.013 | Melatonin receptor 1A antagonist | 0.013 0.012 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.057 | 0.08 | Bombesin 2 receptor antagonist | 0.071 0.019 CHEMBL3527413 0.08 0.017 CHEMBL3526822 0.068 0.02 CHEMBL610 | CHEMBL3526822 | |
| 0.016 | 0.034 | 0.025 | Factor XIII inhibitor | 0.025 0.008 CHEMBL610 | CHEMBL610 | |
| 0.05 | 0.068 | 0.122 | Sphingosine 1-phosphate receptor 4 agonist | 0.122 0.016 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.026 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 CHEMBL610 | CHEMBL610 | |
| 0.034 | 0.052 | 0.043 | Nerve growth factor antagonist | 0.043 0.029 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.063 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.036 CHEMBL610 | CHEMBL610 | |
| 0.039 | 0.057 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CHEMBL3527413 0.051 0.034 CHEMBL3526822 0.06 0.022 CHEMBL610 | CHEMBL610 | |
| 0.061 | 0.079 | 0.133 | Glycine receptor agonist | 0.068 0.059 CHEMBL2074871 0.133 0.009 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.059 | 0.054 | Beta adrenoreceptor agonist | 0.054 0.012 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.024 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 CHEMBL610 | CHEMBL610 | |
| 0.042 | 0.061 | 0.095 | Beta 1 adrenoreceptor antagonist | 0.095 0.011 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.031 | 0.057 | Histamine H4 receptor agonist | 0.057 0.004 CHEMBL610 | CHEMBL610 | |
| 0.012 | 0.032 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.044 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.044 0.009 CHEMBL610 | CHEMBL610 | |
| 0.107 | 0.128 | 0.26 | Acetylcholine M1 receptor antagonist | 0.26 0.023 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.06 | 0.061 | Prolyl endopeptidase inhibitor | 0.061 0.023 CHEMBL610 | CHEMBL610 | |
| 0.031 | 0.052 | 0.123 | 5 Hydroxytryptamine 2B agonist | 0.123 0.004 CHEMBL610 | CHEMBL610 | |
| 0.013 | 0.034 | 0.031 | Dopamine autoreceptor agonist | 0.031 0.013 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.044 | 0.029 | Hedgehog signaling activator | 0.029 0.015 CHEMBL610 | CHEMBL610 | |
| 0.037 | 0.058 | 0.073 | Beta 2 adrenoreceptor antagonist | 0.073 0.015 CHEMBL610 | CHEMBL610 | |
| 0.1 | 0.122 | 0.162 | Sphingosine 1-phosphate receptor 4 antagonist | 0.109 0.095 CHEMBL2074871 0.162 0.024 CHEMBL610 | CHEMBL610 | |
| 0.007 | 0.029 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.009 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.032 | 0.046 | Aminopeptidase A inhibitor | 0.046 0.004 CHEMBL3527413 0.041 0.004 CHEMBL3526822 0.019 0.012 CHEMBL610 | CHEMBL3527413 | |
| 0.059 | 0.082 | 0.08 | MDM2 inhibitor | 0.08 0.019 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.043 | 0.046 | Thrombin receptor antagonist | 0.046 0.01 CHEMBL610 | CHEMBL610 | |
| 0.059 | 0.082 | 0.079 | Adenosine A3 receptor antagonist | 0.079 0.045 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.048 | 0.039 | Histone deacetylase 7 inhibitor | 0.039 0.024 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.033 | 0.023 | Carbonic anhydrase X inhibitor | 0.023 0.006 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.033 | 0.023 | Carbonic anhydrase VIII inhibitor | 0.023 0.006 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.04 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.017 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.047 | 0.041 | Melatonin agonist | 0.041 0.014 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.044 | 0.038 | Peptide deformylase inhibitor | 0.038 0.015 CHEMBL3527413 0.028 0.024 CHEMBL3526822 0.034 0.018 CHEMBL610 | CHEMBL3527413 | |
| 0.011 | 0.035 | 0.019 | Neurokinin 1 agonist | 0.018 0.016 CHEMBL3526822 0.019 0.015 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.049 | 0.05 | NMDA receptor subunit 3A antagonist | 0.05 0.02 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.066 | 0.062 | Cytokine production stimulant | 0.062 0.011 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.041 | 0.025 | Prostaglandin F2 alpha agonist | 0.025 0.013 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.074 | 0.056 | Pregnane X receptor antagonist | 0.056 0.04 CHEMBL610 | CHEMBL610 | |
| 0.062 | 0.089 | 0.151 | Ornithine decarboxylase inhibitor | 0.151 0.011 CHEMBL610 | CHEMBL610 | |
| 0.03 | 0.057 | 0.059 | Carbonic anhydrase VII inhibitor | 0.059 0.02 CHEMBL610 | CHEMBL610 | |
| 0.052 | 0.079 | 0.088 | Interferon inducer | 0.088 0.018 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.041 | 0.036 | Glutamate (mGluR1a) agonist | 0.036 0.006 CHEMBL610 | CHEMBL610 | |
| 0.013 | 0.041 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 CHEMBL610 | CHEMBL610 | |
| 0.042 | 0.07 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.034 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.052 | 0.048 | Melanocortin 1 antagonist | 0.048 0.021 CHEMBL610 | CHEMBL610 | |
| 0.105 | 0.133 | 0.131 | Mannose-6-phosphate isomerase inhibitor | 0.131 0.085 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.05 | 0.032 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.032 0.012 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.038 | 0.027 | Alpha 2a adrenoreceptor agonist | 0.027 0.006 CHEMBL610 | CHEMBL610 | |
| 0.037 | 0.067 | 0.069 | Histamine H4 receptor antagonist | 0.069 0.013 CHEMBL610 | CHEMBL610 | |
| 0.116 | 0.145 | 0.133 | Pregnane X receptor agonist | 0.133 0.091 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.053 | 0.051 | Kainate receptor antagonist | 0.051 0.02 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.053 | 0.072 | Dipeptidyl peptidase II inhibitor | 0.072 0.005 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.055 | 0.041 | Carboxypeptidase B inhibitor | 0.036 0.018 CHEMBL3527413 0.041 0.012 CHEMBL3526822 0.04 0.013 CHEMBL610 | CHEMBL3526822 | |
| 0.022 | 0.052 | 0.038 | Melatonin 1 agonist | 0.038 0.017 CHEMBL610 | CHEMBL610 | |
| 0.113 | 0.143 | 0.169 | Neuropeptide Y1 antagonist | 0.169 0.04 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.078 | 0.191 | 5 Hydroxytryptamine 5A antagonist | 0.191 0.005 CHEMBL610 | CHEMBL610 | |
| 0.029 | 0.06 | 0.039 | Histone deacetylase 9 inhibitor | 0.039 0.027 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.04 | 0.025 | Cyclin T1 inhibitor | 0.025 0.007 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.041 | 0.016 | Telomerase stimulant | 0.016 0.015 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.051 | 0.038 | Calcitonin receptor agonist | 0.034 0.023 CHEMBL3527413 0.038 0.021 CHEMBL3526822 0.035 0.023 CHEMBL610 | CHEMBL3526822 | |
| 0.008 | 0.04 | 0.018 | CXC chemokine 4 receptor agonist | 0.018 0.008 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.041 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.011 CHEMBL610 | CHEMBL610 | |
| 0.035 | 0.067 | 0.047 | Potassium channel (Inward rectifier) blocker | 0.047 0.039 CHEMBL610 | CHEMBL610 | |
| 0.042 | 0.074 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.036 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.065 | 0.095 | Carbonic anhydrase XIV inhibitor | 0.095 0.012 CHEMBL610 | CHEMBL610 | |
| 0.034 | 0.068 | 0.044 | Purinergic P2X4 antagonist | 0.044 0.036 CHEMBL610 | CHEMBL610 | |
| 0.028 | 0.062 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.018 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.048 | 0.043 | Uridine phosphorylase inhibitor | 0.043 0.01 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.08 | 0.088 | Sphingosine kinase inhibitor | 0.088 0.012 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.055 | 0.043 | Melatonin 2 agonist | 0.043 0.014 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.045 | 0.049 | Melatonin 1 antagonist | 0.049 0.005 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.079 | 0.108 | 5 Hydroxytryptamine 7 agonist | 0.108 0.006 CHEMBL610 | CHEMBL610 | |
| 0.05 | 0.086 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.052 | 0.076 | Arginase inhibitor | 0.072 0.007 CHEMBL3527413 0.076 0.006 CHEMBL3526822 0.076 0.006 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.05 | 0.085 | Melatonin antagonist | 0.085 0.005 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.052 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 CHEMBL610 | CHEMBL610 | |
| 0.089 | 0.126 | 0.254 | Toll-Like receptor 2 antagonist | 0.238 0.011 CHEMBL3527413 0.103 0.1 CHEMBL2074871 0.254 0.009 CHEMBL3526822 0.187 0.03 CHEMBL610 | CHEMBL3526822 | |
| 0.054 | 0.091 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | 0.112 0.023 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.085 | 0.27 | Catalase inhibitor | 0.27 0.007 CHEMBL3527413 0.178 0.02 CHEMBL3526822 0.104 0.037 CHEMBL610 | CHEMBL3527413 | |
| 0.019 | 0.057 | 0.043 | Myristoyl transferase inhibitor | 0.043 0.005 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.047 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.01 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.043 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.009 CHEMBL610 | CHEMBL610 | |
| 0.113 | 0.152 | 0.145 | Interferon gamma antagonist | 0.145 0.085 CHEMBL610 | CHEMBL610 | |
| 0.07 | 0.11 | 0.089 | Vanilloid agonist | 0.082 0.064 CHEMBL3527413 0.084 0.06 CHEMBL3526822 0.089 0.049 CHEMBL610 | CHEMBL610 | |
| 0.076 | 0.116 | 0.366 | Chelator | 0.366 0.007 CHEMBL3527413 0.191 0.026 CHEMBL3526822 | CHEMBL3527413 | |
| 0.047 | 0.087 | 0.053 | Leukotriene C antagonist | 0.053 0.051 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.083 | 0.184 | 5 Hydroxytryptamine 5 antagonist | 0.184 0.005 CHEMBL610 | CHEMBL610 | |
| 0.182 | 0.222 | 0.374 | Interleukin 2 agonist | 0.366 0.039 CHEMBL3527413 0.351 0.045 CHEMBL3526822 0.374 0.036 CHEMBL610 | CHEMBL610 | |
| 0.032 | 0.073 | 0.08 | Glutamate (mGluR4) antagonist | 0.08 0.008 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.065 | 0.049 | Carbonic anhydrase XII inhibitor | 0.049 0.039 CHEMBL610 | CHEMBL610 | |
| 0.059 | 0.099 | 0.107 | Interferon agonist | 0.107 0.024 CHEMBL610 | CHEMBL610 | |
| 0.102 | 0.143 | 0.256 | Phospholipase A2 inhibitor | 0.232 0.028 CHEMBL3527413 0.256 0.022 CHEMBL3526822 0.199 0.043 CHEMBL610 | CHEMBL3526822 | |
| 0.021 | 0.062 | 0.054 | Cathepsin L1 inhibitor | 0.045 0.022 CHEMBL3526822 0.054 0.018 CHEMBL610 | CHEMBL610 | |
| 0.115 | 0.157 | 0.178 | CF transmembrane conductance regulator agonist | 0.128 0.122 CHEMBL2074871 0.178 0.038 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.069 | 0.064 | AMPA 4 receptor antagonist | 0.036 0.034 CHEMBL3527413 0.04 0.027 CHEMBL3526822 0.064 0.009 CHEMBL610 | CHEMBL610 | |
| 0.035 | 0.077 | 0.11 | Cathepsin L inhibitor | 0.063 0.035 CHEMBL3527413 0.11 0.019 CHEMBL3526822 0.073 0.028 CHEMBL610 | CHEMBL3526822 | |
| 0.029 | 0.071 | 0.055 | Sphingosine kinase 1 inhibitor | 0.055 0.012 CHEMBL610 | CHEMBL610 | |
| 0.066 | 0.109 | 0.124 | Alcohol dehydrogenase inhibitor | 0.106 0.046 CHEMBL3527413 0.124 0.032 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.089 | 0.104 | Beta adrenoreceptor antagonist | 0.104 0.015 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.066 | 0.223 | Toll-Like receptor 2 agonist | 0.22 0.006 CHEMBL3527413 0.223 0.006 CHEMBL3526822 0.05 0.024 CHEMBL610 | CHEMBL3526822 | |
| 0.012 | 0.056 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.013 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.063 | 0.037 | Retinoid X alpha receptor agonist | 0.037 0.022 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.061 | 0.058 | Kainate receptor 2 antagonist | 0.058 0.013 CHEMBL610 | CHEMBL610 | |
| 0.057 | 0.102 | 0.1 | Keratolytic | 0.1 0.03 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.072 | 0.038 | Adenosine uptake inhibitor | 0.038 0.015 CHEMBL610 | CHEMBL610 | |
| 0.153 | 0.198 | 0.241 | DNA synthesis inhibitor | 0.241 0.072 CHEMBL610 | CHEMBL610 | |
| 0.111 | 0.157 | 0.512 | Psychostimulant | 0.145 0.121 CHEMBL2074871 0.512 0.01 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.082 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.06 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.007 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.06 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 CHEMBL610 | CHEMBL610 | |
| 0.028 | 0.077 | 0.053 | Plasmepsin II inhibitor | 0.053 0.016 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.072 | 0.332 | Glycine transporter 2 inhibitor | 0.332 0.003 CHEMBL3527413 0.32 0.004 CHEMBL3526822 0.089 0.015 CHEMBL610 | CHEMBL3527413 | |
| 0.05 | 0.099 | 0.152 | Analgesic, opioid | 0.152 0.014 CHEMBL3526822 0.072 0.058 CHEMBL610 | CHEMBL3526822 | |
| 0.023 | 0.072 | 0.066 | Glutamate (mGluR3) antagonist | 0.066 0.007 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.09 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.041 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.098 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.059 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.066 | 0.082 | Sirtuin 2 inhibitor | 0.082 0.005 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.077 | 0.103 | Ribonucleoside-diphosphate reductase inhibitor | 0.103 0.019 CHEMBL3527413 0.095 0.02 CHEMBL3526822 0.049 0.041 CHEMBL610 | CHEMBL3527413 | |
| 0.012 | 0.066 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.016 0.015 CHEMBL3527413 0.017 0.013 CHEMBL3526822 0.017 0.013 CHEMBL610 | CHEMBL610 | |
| 0.038 | 0.092 | 0.111 | Alpha 2 adrenoreceptor agonist | 0.111 0.012 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.079 | 0.102 | Ribonucleotide reductase inhibitor | 0.102 0.02 CHEMBL3527413 0.094 0.022 CHEMBL3526822 0.053 0.04 CHEMBL610 | CHEMBL3527413 | |
| 0.037 | 0.094 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 CHEMBL610 | CHEMBL610 | |
| 0.164 | 0.221 | 0.265 | Vasodilator, peripheral | 0.265 0.117 CHEMBL610 | CHEMBL610 | |
| 0.034 | 0.092 | 0.057 | Leukotriene B4 antagonist | 0.057 0.032 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.081 | 0.101 | Antimetabolite | 0.047 0.033 CHEMBL3527413 0.101 0.016 CHEMBL3526822 0.041 0.039 CHEMBL610 | CHEMBL3526822 | |
| 0.078 | 0.137 | 0.125 | Nav1.5 sodium channel blocker | 0.125 0.049 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.096 | 0.063 | CD45 antagonist | 0.063 0.019 CHEMBL3527413 0.053 0.03 CHEMBL3526822 0.049 0.037 CHEMBL610 | CHEMBL3527413 | |
| 0.02 | 0.08 | 0.05 | Factor XIIIa inhibitor | 0.042 0.021 CHEMBL3527413 0.043 0.021 CHEMBL3526822 0.05 0.016 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.082 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 CHEMBL610 | CHEMBL610 | |
| 0.044 | 0.105 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | 0.08 0.017 CHEMBL610 | CHEMBL610 | |
| 0.029 | 0.091 | 0.157 | 5 Hydroxytryptamine 2 agonist | 0.157 0.005 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.087 | 0.074 | Metalloproteinase-3 inhibitor | 0.074 0.018 CHEMBL3527413 0.062 0.023 CHEMBL3526822 | CHEMBL3527413 | |
| 0.026 | 0.088 | 0.059 | Dopamine transporter inhibitor | 0.059 0.025 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.085 | 0.034 | Delayed rectifier potassium channel blocker | 0.034 0.032 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.107 | 0.106 | Cathepsin G inhibitor | 0.106 0.031 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.085 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.033 CHEMBL610 | CHEMBL610 | |
| 0.041 | 0.104 | 0.167 | NMDA receptor agonist | 0.075 0.032 CHEMBL3527413 0.085 0.026 CHEMBL3526822 0.167 0.006 CHEMBL610 | CHEMBL610 | |
| 0.072 | 0.136 | 0.196 | Mucolytic | 0.179 0.019 CHEMBL3527413 0.196 0.014 CHEMBL3526822 0.148 0.033 CHEMBL610 | CHEMBL3526822 | |
| 0.072 | 0.138 | 0.133 | Amylase inhibitor | 0.133 0.073 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.089 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 CHEMBL610 | CHEMBL610 | |
| 0.031 | 0.1 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 CHEMBL610 | CHEMBL610 | |
| 0.049 | 0.117 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.045 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.093 | 0.053 | Thymidylate synthase inhibitor | 0.042 0.038 CHEMBL3527413 0.053 0.024 CHEMBL3526822 | CHEMBL3526822 | |
| 0.007 | 0.077 | 0.023 | Growth hormone releasing factor antagonist | 0.023 0.017 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.108 | 0.075 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 CHEMBL3526822 0.075 0.02 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.094 | 0.042 | Oleamide hydrolase inhibitor | 0.042 0.035 CHEMBL610 | CHEMBL610 | |
| 0.057 | 0.131 | 0.296 | Glutathione S-transferase inhibitor | 0.296 0.003 CHEMBL3527413 0.292 0.003 CHEMBL3526822 0.084 0.056 CHEMBL610 | CHEMBL3527413 | |
| 0.032 | 0.106 | 0.075 | Acetylcholine M5 receptor antagonist | 0.075 0.027 CHEMBL610 | CHEMBL610 | |
| 0.068 | 0.142 | 0.182 | Proteasome inhibitor | 0.182 0.031 CHEMBL3527413 0.128 0.059 CHEMBL3526822 0.116 0.068 CHEMBL610 | CHEMBL3527413 | |
| 0.015 | 0.089 | 0.031 | Glutamate (mGluR1) agonist | 0.031 0.009 CHEMBL3526822 0.028 0.012 CHEMBL610 | CHEMBL3526822 | |
| 0.051 | 0.126 | 0.171 | Monophenol monooxygenase inhibitor | 0.138 0.052 CHEMBL3527413 0.171 0.04 CHEMBL3526822 0.122 0.06 CHEMBL610 | CHEMBL3526822 | |
| 0.068 | 0.144 | 0.174 | Acetylcholine muscarinic antagonist | 0.174 0.032 CHEMBL610 | CHEMBL610 | |
| 0.032 | 0.108 | 0.064 | Acetylcholine M5 receptor agonist | 0.064 0.05 CHEMBL610 | CHEMBL610 | |
| 0.013 | 0.089 | 0.074 | Complement C3a chemotactic receptor antagonist | 0.068 0.018 CHEMBL3527413 0.074 0.016 CHEMBL3526822 0.071 0.017 CHEMBL610 | CHEMBL3526822 | |
| 0.024 | 0.101 | 0.122 | Plasmin inhibitor | 0.122 0.014 CHEMBL610 | CHEMBL610 | |
| 0.169 | 0.247 | 0.418 | Histamine release inhibitor | 0.309 0.119 CHEMBL3527413 0.207 0.194 CHEMBL2074871 0.418 0.066 CHEMBL3526822 0.378 0.087 CHEMBL610 | CHEMBL3526822 | |
| 0.036 | 0.114 | 0.059 | Dopamine D1 antagonist | 0.059 0.052 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.095 | 0.082 | Vascular adhesion protein 1 inhibitor | 0.082 0.005 CHEMBL610 | CHEMBL610 | |
| 0.063 | 0.142 | 0.169 | Anesthetic local | 0.169 0.041 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.124 | 0.071 | Epoxide hydrolase inhibitor | 0.071 0.052 CHEMBL2074871 | CHEMBL2074871 | |
| 0.049 | 0.129 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.052 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.103 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.025 CHEMBL610 | CHEMBL610 | |
| 0.039 | 0.121 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | 0.078 0.019 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.107 | 0.053 | Neurokinin 2 agonist | 0.047 0.022 CHEMBL3527413 0.048 0.021 CHEMBL3526822 0.053 0.017 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.101 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.033 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.113 | 0.148 | Neutrophil collagenase inhibitor | 0.148 0.013 CHEMBL3527413 0.124 0.016 CHEMBL3526822 0.063 0.047 CHEMBL610 | CHEMBL3527413 | |
| 0.013 | 0.102 | 0.093 | Calcium-sensing receptor agonist | 0.034 0.01 CHEMBL3527413 0.093 0.003 CHEMBL3526822 0.027 0.017 CHEMBL610 | CHEMBL3526822 | |
| 0.015 | 0.105 | 0.036 | Bombesin 1 receptor antagonist | 0.036 0.027 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.15 | 0.083 | mTOR complex 2 inhibitor | 0.083 0.061 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.1 | 0.041 | AMPA 3 receptor antagonist | 0.041 0.013 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.095 | 0.018 | Ileal bile acid transport inhibitor | 0.018 0.01 CHEMBL3526822 | CHEMBL3526822 | |
| 0.071 | 0.162 | 0.166 | Nav1.6 sodium channel blocker | 0.166 0.038 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.134 | 0.076 | Calcium channel L-type blocker | 0.076 0.044 CHEMBL610 | CHEMBL610 | |
| 0.081 | 0.174 | 0.22 | Protein kinase stimulant | 0.22 0.035 CHEMBL610 | CHEMBL610 | |
| 0.068 | 0.161 | 0.106 | Microtubule formation inhibitor | 0.106 0.08 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.118 | 0.048 | Nicotinic receptor alpha3 subunit antagonist | 0.048 0.027 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.158 | 0.097 | Bile acid receptor antagonist | 0.097 0.056 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.105 | 0.018 | Complement factor D inhibitor | 0.018 0.012 CHEMBL610 | CHEMBL610 | |
| 0.147 | 0.247 | 0.295 | Transcription factor STAT inhibitor | 0.295 0.059 CHEMBL610 | CHEMBL610 | |
| 0.037 | 0.138 | 0.111 | Sirtuin 1 inhibitor | 0.111 0.018 CHEMBL3527413 0.1 0.023 CHEMBL3526822 0.105 0.02 CHEMBL610 | CHEMBL3527413 | |
| 0.026 | 0.129 | 0.063 | GABA B receptor antagonist | 0.063 0.011 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.13 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.032 CHEMBL3527413 0.059 0.033 CHEMBL3526822 | CHEMBL3527413 | |
| 0.135 | 0.239 | 0.25 | Transcription factor STAT3 inhibitor | 0.25 0.083 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.132 | 0.09 | 5 Hydroxytryptamine 6 antagonist | 0.09 0.018 CHEMBL610 | CHEMBL610 | |
| 0.012 | 0.118 | 0.038 | 5 Hydroxytryptamine 3B antagonist | 0.038 0.023 CHEMBL610 | CHEMBL610 | |
| 0.012 | 0.119 | 0.022 | ICAM 1 antagonist | 0.022 0.019 CHEMBL610 | CHEMBL610 | |
| 0.104 | 0.211 | 0.165 | 3C-like protease (Human coronavirus) inhibitor | 0.165 0.08 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.143 | 0.088 | Acetylcholine M4 receptor antagonist | 0.088 0.039 CHEMBL610 | CHEMBL610 | |
| 0.056 | 0.166 | 0.165 | Alpha 2b adrenoreceptor antagonist | 0.165 0.033 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.126 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.053 0.017 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.122 | 0.025 | LFA antagonist | 0.025 0.024 CHEMBL610 | CHEMBL610 | |
| 0.095 | 0.207 | 0.298 | DNA methylase inhibitor | 0.298 0.028 CHEMBL3527413 0.194 0.083 CHEMBL3526822 0.206 0.076 CHEMBL610 | CHEMBL3527413 | |
| 0.015 | 0.127 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.132 | 0.037 | Glutamate (mGluR1a) antagonist | 0.037 0.034 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.139 | 0.065 | Nicotinic receptor alpha7 subunit antagonist | 0.065 0.025 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.125 | 0.132 | Melanocortin 5 antagonist | 0.132 0.006 CHEMBL610 | CHEMBL610 | |
| 0.039 | 0.154 | 0.083 | Alpha adrenoreceptor antagonist | 0.083 0.069 CHEMBL610 | CHEMBL610 | |
| 0.029 | 0.145 | 0.139 | Alpha adrenoreceptor agonist | 0.139 0.018 CHEMBL610 | CHEMBL610 | |
| 0.041 | 0.157 | 0.156 | Somatostatin 1 agonist | 0.097 0.036 CHEMBL3527413 0.1 0.034 CHEMBL3526822 0.156 0.012 CHEMBL610 | CHEMBL610 | |
| 0.065 | 0.182 | 0.087 | Phosphodiesterase 6D inhibitor | 0.087 0.086 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.139 | 0.095 | Acetylcholine M3 receptor antagonist | 0.095 0.019 CHEMBL610 | CHEMBL610 | |
| 0.074 | 0.191 | 0.153 | Interleukin 8 antagonist | 0.153 0.032 CHEMBL610 | CHEMBL610 | |
| 0.069 | 0.188 | 0.204 | NADPH oxidase inhibitor | 0.204 0.033 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.132 | 0.083 | TRPM8 blocker | 0.083 0.008 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.124 | 0.032 | AMPA 1 receptor antagonist | 0.032 0.019 CHEMBL610 | CHEMBL610 | |
| 0.083 | 0.204 | 0.153 | Hexokinase inhibitor | 0.153 0.075 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.146 | 0.146 | 5 Hydroxytryptamine 1D antagonist | 0.146 0.012 CHEMBL610 | CHEMBL610 | |
| 0.113 | 0.237 | 0.171 | Cyclic AMP phosphodiesterase inhibitor | 0.171 0.121 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.183 | 0.173 | Cholinergic antagonist | 0.173 0.041 CHEMBL610 | CHEMBL610 | |
| 0.049 | 0.172 | 0.178 | Expectorant | 0.155 0.033 CHEMBL3527413 0.178 0.026 CHEMBL3526822 0.117 0.053 CHEMBL610 | CHEMBL3526822 | |
| 0.059 | 0.183 | 0.17 | Acetylcholine antagonist | 0.17 0.04 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.142 | 0.047 | Matrix metalloproteinase 1 inhibitor | 0.047 0.04 CHEMBL3527413 | CHEMBL3527413 | |
| 0.026 | 0.152 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.046 0.041 CHEMBL3526822 | CHEMBL3526822 | |
| 0.025 | 0.152 | 0.105 | 5 Hydroxytryptamine 1B antagonist | 0.105 0.021 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.154 | 0.092 | Neuronal nicotinic receptor antagonist | 0.092 0.028 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.134 | 0.027 | Aminopeptidase P inhibitor | 0.026 0.013 CHEMBL3527413 0.027 0.012 CHEMBL3526822 | CHEMBL3526822 | |
| 0.038 | 0.167 | 0.073 | Secretase beta inhibitor | 0.073 0.045 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.157 | 0.548 | 5 Hydroxytryptamine 1B agonist | 0.548 0.003 CHEMBL610 | CHEMBL610 | |
| 0.012 | 0.142 | 0.025 | 5 Hydroxytryptamine 4 agonist | 0.025 0.015 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.158 | 0.062 | Cyclin D1 inhibitor | 0.062 0.039 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.166 | 0.054 | DNA helicase inhibitor | 0.054 0.038 CHEMBL3527413 | CHEMBL3527413 | |
| 0.018 | 0.151 | 0.051 | Sphingosine 1-phosphate receptor agonist | 0.051 0.024 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.167 | 0.125 | Acetylcholine nicotinic antagonist | 0.125 0.029 CHEMBL610 | CHEMBL610 | |
| 0.012 | 0.146 | 0.475 | 5 Hydroxytryptamine 1 agonist | 0.475 0.004 CHEMBL610 | CHEMBL610 | |
| 0.084 | 0.219 | 0.252 | DNA methyltransferase I inhibitor | 0.252 0.046 CHEMBL3527413 0.138 0.119 CHEMBL3526822 0.136 0.121 CHEMBL610 | CHEMBL3527413 | |
| 0.044 | 0.18 | 0.104 | Antihistaminic | 0.104 0.052 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.164 | 0.07 | Amidase inhibitor | 0.07 0.048 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.175 | 0.095 | Histamine antagonist | 0.095 0.051 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.16 | 0.082 | Acetylcholine M2 receptor antagonist | 0.082 0.028 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.18 | 0.083 | Metalloproteinase-9 inhibitor | 0.083 0.042 CHEMBL3527413 0.079 0.044 CHEMBL3526822 | CHEMBL3527413 | |
| 0.006 | 0.149 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 CHEMBL610 | CHEMBL610 | |
| 0.028 | 0.172 | 0.071 | Dipeptidyl peptidase inhibitor | 0.071 0.017 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.169 | 0.11 | Matrix metalloproteinase inhibitor | 0.11 0.023 CHEMBL3527413 0.088 0.032 CHEMBL3526822 | CHEMBL3527413 | |
| 0.009 | 0.153 | 0.029 | Somatostatin 4 antagonist | 0.029 0.012 CHEMBL610 | CHEMBL610 | |
| 0.156 | 0.3 | 0.262 | Ca(v)3.3 blocker | 0.262 0.083 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.17 | 0.047 | Dipeptidyl peptidase IV inhibitor | 0.047 0.025 CHEMBL610 | CHEMBL610 | |
| 0.132 | 0.281 | 0.303 | Antithrombotic | 0.226 0.148 CHEMBL3527413 0.266 0.114 CHEMBL3526822 0.303 0.086 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.184 | 0.1 | Metalloproteinase-2 inhibitor | 0.1 0.038 CHEMBL3527413 0.071 0.064 CHEMBL2074871 0.092 0.042 CHEMBL3526822 | CHEMBL3527413 | |
| 0.02 | 0.174 | 0.057 | 5 Hydroxytryptamine 3 antagonist | 0.057 0.04 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.172 | 0.077 | Alpha 1 adrenoreceptor agonist | 0.077 0.024 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.178 | 0.079 | 5 Hydroxytryptamine 3A antagonist | 0.079 0.032 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.169 | 0.119 | Urokinase inhibitor | 0.119 0.012 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.212 | 0.096 | Interleukin 1 beta converting enzyme inhibitor | 0.096 0.063 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.178 | 0.085 | Melanocortin antagonist | 0.085 0.013 CHEMBL610 | CHEMBL610 | |
| 0.126 | 0.292 | 0.215 | Immunosuppressant | 0.215 0.181 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.186 | 0.069 | Cyclin A1 inhibitor | 0.069 0.024 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.193 | 0.105 | Histamine H1 receptor antagonist | 0.105 0.039 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.186 | 0.06 | 5 Hydroxytryptamine 4 antagonist | 0.06 0.023 CHEMBL610 | CHEMBL610 | |
| 0.017 | 0.186 | 0.083 | Toll-Like receptor 8 antagonist | 0.083 0.016 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.193 | 0.168 | CXC chemokine 4 receptor antagonist | 0.168 0.013 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.197 | 0.051 | Cathepsin D inhibitor | 0.051 0.041 CHEMBL3527413 0.048 0.045 CHEMBL3526822 | CHEMBL3527413 | |
| 0.012 | 0.188 | 0.046 | Adenosine A2b receptor antagonist | 0.046 0.039 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.205 | 0.165 | 5 Hydroxytryptamine 2C antagonist | 0.165 0.023 CHEMBL610 | CHEMBL610 | |
| 0.094 | 0.271 | 0.145 | ATPase inhibitor | 0.145 0.11 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.201 | 0.049 | Lysine-specific demethylase 1A inhibitor | 0.049 0.048 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.206 | 0.071 | Bombesin 1 receptor agonist | 0.068 0.033 CHEMBL3527413 0.071 0.031 CHEMBL3526822 | CHEMBL3526822 | |
| 0.047 | 0.228 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.191 | 0.062 | Melanocortin 4 antagonist | 0.062 0.018 CHEMBL610 | CHEMBL610 | |
| 0.007 | 0.189 | 0.033 | Urotensin II agonist | 0.033 0.013 CHEMBL610 | CHEMBL610 | |
| 0.095 | 0.278 | 0.345 | Cardiotonic | 0.345 0.04 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.204 | 0.05 | Bombesin antagonist | 0.049 0.031 CHEMBL3527413 0.05 0.029 CHEMBL3526822 | CHEMBL3526822 | |
| 0.041 | 0.227 | 0.171 | 5 Hydroxytryptamine 2B antagonist | 0.171 0.033 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.201 | 0.076 | Aminopeptidase N inhibitor | 0.073 0.019 CHEMBL3527413 0.076 0.018 CHEMBL3526822 0.047 0.035 CHEMBL610 | CHEMBL3526822 | |
| 0.013 | 0.202 | 0.097 | Somatostatin 5 agonist | 0.097 0.005 CHEMBL610 | CHEMBL610 | |
| 0.075 | 0.266 | 0.377 | Growth hormone agonist | 0.343 0.024 CHEMBL3527413 0.355 0.023 CHEMBL3526822 0.377 0.019 CHEMBL610 | CHEMBL610 | |
| 0.02 | 0.212 | 0.096 | Aminopeptidase microsomal inhibitor | 0.095 0.019 CHEMBL3527413 0.096 0.019 CHEMBL3526822 0.066 0.035 CHEMBL610 | CHEMBL3526822 | |
| 0.011 | 0.214 | 0.078 | 5 Hydroxytryptamine 1A antagonist | 0.078 0.041 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.246 | 0.257 | Alkylator | 0.257 0.016 CHEMBL3526822 0.126 0.063 CHEMBL610 | CHEMBL3526822 | |
| 0.094 | 0.297 | 0.314 | DNA damaging | 0.204 0.112 CHEMBL3526822 0.314 0.052 CHEMBL610 | CHEMBL610 | |
| 0.043 | 0.248 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.214 | 0.042 | AMPA receptor antagonist | 0.042 0.04 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.224 | 0.127 | 5 Hydroxytryptamine 2A antagonist | 0.127 0.035 CHEMBL610 | CHEMBL610 | |
| 0.046 | 0.252 | 0.116 | Caspase 3 inhibitor | 0.111 0.074 CHEMBL3527413 0.116 0.065 CHEMBL3526822 | CHEMBL3526822 | |
| 0.012 | 0.223 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 CHEMBL2074871 | CHEMBL2074871 | |
| 0.063 | 0.279 | 0.151 | Factor V inhibitor | 0.148 0.019 CHEMBL3527413 0.151 0.018 CHEMBL3526822 0.115 0.044 CHEMBL610 | CHEMBL3526822 | |
| 0.013 | 0.231 | 0.055 | Growth hormone release inhibitor | 0.046 0.025 CHEMBL3527413 0.048 0.023 CHEMBL3526822 0.055 0.019 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.233 | 0.089 | 5 Hydroxytryptamine 1 antagonist | 0.089 0.042 CHEMBL610 | CHEMBL610 | |
| 0.075 | 0.297 | 0.203 | Tumour necrosis factor antagonist | 0.203 0.051 CHEMBL610 | CHEMBL610 | |
| 0.056 | 0.28 | 0.234 | Histone deacetylase SIRT1 inhibitor | 0.234 0.021 CHEMBL3527413 0.203 0.029 CHEMBL3526822 0.209 0.027 CHEMBL610 | CHEMBL3527413 | |
| 0.018 | 0.243 | 0.053 | Neurotensin receptor antagonist | 0.051 0.028 CHEMBL3527413 0.053 0.026 CHEMBL3526822 0.043 0.033 CHEMBL610 | CHEMBL3526822 | |
| 0.011 | 0.237 | 0.062 | Alpha 1b adrenoreceptor antagonist | 0.062 0.059 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.232 | 0.051 | Somatostatin 2 antagonist | 0.051 0.015 CHEMBL610 | CHEMBL610 | |
| 0.038 | 0.264 | 0.094 | Protein kinase C zeta inhibitor | 0.094 0.058 CHEMBL610 | CHEMBL610 | |
| 0.069 | 0.3 | 0.164 | Antiamyloidogenic | 0.164 0.129 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.25 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.032 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.242 | 0.05 | Glutamate (mGluR1) antagonist | 0.05 0.048 CHEMBL610 | CHEMBL610 | |
| 0.07 | 0.305 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | 0.118 0.058 CHEMBL610 | CHEMBL610 | |
| 0.092 | 0.328 | 0.182 | Histone acetyltransferase inhibitor | 0.182 0.096 CHEMBL610 | CHEMBL610 | |
| 0.061 | 0.297 | 0.147 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.083 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.265 | 0.164 | 5 Hydroxytryptamine 2 antagonist | 0.164 0.04 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.256 | 0.037 | Somatostatin 4 agonist | 0.037 0.026 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.265 | 0.116 | Adrenaline antagonist | 0.116 0.045 CHEMBL610 | CHEMBL610 | |
| 0.025 | 0.267 | 0.126 | Antiadrenergic | 0.126 0.043 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.266 | 0.077 | I kappa B kinase 2 inhibitor | 0.077 0.024 CHEMBL610 | CHEMBL610 | |
| 0.019 | 0.265 | 0.049 | Cathepsin F inhibitor | 0.048 0.016 CHEMBL3527413 0.049 0.014 CHEMBL3526822 | CHEMBL3526822 | |
| 0.005 | 0.251 | 0.04 | Protease activated receptor 1 antagonist | 0.04 0.037 CHEMBL610 | CHEMBL610 | |
| 0.003 | 0.25 | 0.097 | Neutral endopeptidase inhibitor | 0.027 0.012 CHEMBL3527413 0.097 0.005 CHEMBL3526822 | CHEMBL3526822 | |
| 0.035 | 0.283 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.077 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.268 | 0.051 | Pim-2 kinase inhibitor | 0.051 0.043 CHEMBL610 | CHEMBL610 | |
| 0.024 | 0.279 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.051 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.267 | 0.06 | Endothelin-converting enzyme inhibitor | 0.058 0.026 CHEMBL3527413 0.06 0.025 CHEMBL3526822 | CHEMBL3526822 | |
| 0.047 | 0.303 | 0.116 | Calcium channel blocker | 0.116 0.092 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.283 | 0.106 | Carbonic anhydrase II stimulant | 0.069 0.015 CHEMBL3527413 0.063 0.02 CHEMBL3526822 0.106 0.005 CHEMBL610 | CHEMBL610 | |
| 0.017 | 0.28 | 0.071 | Rho-associated kinase I inhibitor | 0.071 0.056 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.291 | 0.134 | 5 Hydroxytryptamine antagonist | 0.134 0.057 CHEMBL610 | CHEMBL610 | |
| 0.002 | 0.275 | 0.015 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.01 CHEMBL3527413 0.015 0.01 CHEMBL3526822 | CHEMBL3526822 | |
| 0.045 | 0.319 | 0.141 | LIM domain kinase 1 inhibitor | 0.141 0.107 CHEMBL610 | CHEMBL610 | |
| 0.051 | 0.327 | 0.141 | I kappa B kinase epsilon inhibitor | 0.141 0.13 CHEMBL610 | CHEMBL610 | |
| 0.06 | 0.341 | 0.154 | Sigma receptor agonist | 0.154 0.083 CHEMBL610 | CHEMBL610 | |
| 0.091 | 0.375 | 0.333 | 15-Lipoxygenase inhibitor | 0.333 0.109 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.317 | 0.21 | M18 aspartyl aminopeptidase inhibitor | 0.21 0.031 CHEMBL610 | CHEMBL610 | |
| 0.045 | 0.341 | 0.15 | Toll-Like receptor 3 antagonist | 0.15 0.014 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.311 | 0.079 | Tryptase inhibitor | 0.079 0.006 CHEMBL610 | CHEMBL610 | |
| 0.036 | 0.342 | 0.116 | DNA polymerase I inhibitor | 0.116 0.072 CHEMBL610 | CHEMBL610 | |
| 0.013 | 0.319 | 0.048 | Cholecystokinin B agonist | 0.046 0.018 CHEMBL3527413 0.048 0.017 CHEMBL3526822 | CHEMBL3526822 | |
| 0.042 | 0.355 | 0.14 | Cytokine production inhibitor | 0.14 0.07 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.322 | 0.066 | Somatostatin 1 antagonist | 0.066 0.013 CHEMBL610 | CHEMBL610 | |
| 0.035 | 0.351 | 0.139 | Beta amyloid protein antagonist | 0.139 0.049 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.34 | 0.097 | I kappa B kinase inhibitor | 0.097 0.041 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.33 | 0.067 | Erythropoietin receptor agonist | 0.062 0.017 CHEMBL3527413 0.067 0.015 CHEMBL3526822 | CHEMBL3526822 | |
| 0.012 | 0.333 | 0.107 | Histone deacetylase SIRT2 inhibitor | 0.107 0.024 CHEMBL610 | CHEMBL610 | |
| 0.128 | 0.452 | 0.253 | MAP kinase kinase 6 inhibitor | 0.253 0.186 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.35 | 0.058 | Cathepsin E inhibitor | 0.058 0.044 CHEMBL3527413 0.057 0.045 CHEMBL3526822 | CHEMBL3527413 | |
| 0.03 | 0.356 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.079 CHEMBL610 | CHEMBL610 | |
| 0.031 | 0.358 | 0.116 | GABA receptor agonist | 0.116 0.06 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.359 | 0.074 | Cathepsin B inhibitor | 0.068 0.03 CHEMBL3527413 0.074 0.026 CHEMBL3526822 | CHEMBL3526822 | |
| 0.013 | 0.361 | 0.085 | Angiotensin-converting enzyme inhibitor | 0.083 0.012 CHEMBL3527413 0.085 0.012 CHEMBL3526822 | CHEMBL3526822 | |
| 0.003 | 0.356 | 0.019 | Growth hormone release promoting | 0.019 0.014 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.366 | 0.064 | Maillard reaction inhibitor | 0.064 0.032 CHEMBL610 | CHEMBL610 | |
| 0.014 | 0.37 | 0.07 | Neuropeptide agonist | 0.048 0.043 CHEMBL3527413 0.053 0.041 CHEMBL3526822 0.07 0.035 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.39 | 0.158 | Toll-Like receptor antagonist | 0.158 0.05 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.367 | 0.211 | 5 Hydroxytryptamine 1F antagonist | 0.211 0.009 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.379 | 0.047 | Glutamate (mGluR8) antagonist | 0.046 0.011 CHEMBL3527413 0.047 0.01 CHEMBL3526822 0.038 0.02 CHEMBL610 | CHEMBL3526822 | |
| 0.025 | 0.39 | 0.16 | Histone deacetylase class III inhibitor | 0.16 0.037 CHEMBL3527413 0.144 0.048 CHEMBL3526822 0.16 0.037 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.37 | 0.215 | Leukotriene A4 hydrolase inhibitor | 0.132 0.005 CHEMBL3527413 0.215 0.004 CHEMBL3526822 0.127 0.005 CHEMBL610 | CHEMBL3526822 | |
| 0.009 | 0.377 | 0.087 | Glutamate receptor agonist | 0.087 0.047 CHEMBL610 | CHEMBL610 | |
| 0.048 | 0.417 | 0.217 | Hemostatic | 0.217 0.027 CHEMBL610 | CHEMBL610 | |
| 0.071 | 0.441 | 0.192 | Death-associated protein kinase 2 inhibitor | 0.192 0.041 CHEMBL610 | CHEMBL610 | |
| 0.016 | 0.386 | 0.115 | Thrombin inhibitor | 0.068 0.058 CHEMBL3527413 0.071 0.053 CHEMBL3526822 0.115 0.019 CHEMBL610 | CHEMBL610 | |
| 0.032 | 0.403 | 0.161 | MAP kinase kinase 2 inhibitor | 0.161 0.111 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.38 | 0.568 | 5 Hydroxytryptamine agonist | 0.568 0.004 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.382 | 0.053 | Collagenase inhibitor | 0.053 0.027 CHEMBL3527413 0.052 0.028 CHEMBL3526822 | CHEMBL3527413 | |
| 0.005 | 0.387 | 0.043 | Growth hormone releasing factor agonist | 0.043 0.016 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.4 | 0.033 | Bradykinin B2 receptor agonist | 0.032 0.017 CHEMBL3527413 0.033 0.016 CHEMBL3526822 | CHEMBL3526822 | |
| 0.014 | 0.409 | 0.084 | Protein kinase C iota inhibitor | 0.084 0.024 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.403 | 0.031 | Renin inhibitor | 0.031 0.03 CHEMBL3526822 | CHEMBL3526822 | |
| 0.01 | 0.411 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.414 | 0.059 | 5 Hydroxytryptamine uptake inhibitor | 0.059 0.047 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.415 | 0.018 | Somatostatin 3 antagonist | 0.018 0.016 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.418 | 0.058 | Dopamine D2 agonist | 0.058 0.022 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.419 | 0.028 | Histone deacetylase 5 inhibitor | 0.028 0.027 CHEMBL3526822 | CHEMBL3526822 | |
| 0.005 | 0.419 | 0.103 | 5 Hydroxytryptamine 2C agonist | 0.103 0.007 CHEMBL610 | CHEMBL610 | |
| 0.026 | 0.446 | 0.06 | Kallikrein 1 inhibitor | 0.06 0.033 CHEMBL610 | CHEMBL610 | |
| 0.044 | 0.488 | 0.151 | Folate antagonist | 0.148 0.023 CHEMBL3527413 0.151 0.022 CHEMBL3526822 | CHEMBL3526822 | |
| 0.004 | 0.45 | 0.052 | Histamine H3 receptor agonist | 0.052 0.01 CHEMBL610 | CHEMBL610 | |
| 0.04 | 0.488 | 0.179 | Antipruritic | 0.179 0.065 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.458 | 0.034 | Dipeptidyl peptidase I inhibitor | 0.034 0.017 CHEMBL610 | CHEMBL610 | |
| 0.007 | 0.469 | 0.05 | Somatostatin agonist | 0.05 0.013 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.477 | 0.044 | Macrophage elastase inhibitor | 0.042 0.031 CHEMBL3527413 0.044 0.03 CHEMBL3526822 | CHEMBL3526822 | |
| 0.065 | 0.542 | 0.138 | Catenin beta inhibitor | 0.138 0.137 CHEMBL610 | CHEMBL610 | |
| 0.062 | 0.556 | 0.426 | Sodium/bile acid cotransporter inhibitor | 0.414 0.013 CHEMBL3527413 0.426 0.011 CHEMBL3526822 | CHEMBL3526822 | |
| 0.1 | 0.601 | 0.228 | MAP kinase kinase 3 inhibitor | 0.228 0.059 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.512 | 0.073 | Adrenaline uptake inhibitor | 0.073 0.032 CHEMBL610 | CHEMBL610 | |
| 0.082 | 0.587 | 0.301 | Peptidyltransferase inhibitor | 0.275 0.035 CHEMBL3527413 0.281 0.032 CHEMBL3526822 0.301 0.024 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.528 | 0.285 | Anticonvulsant | 0.285 0.045 CHEMBL610 | CHEMBL610 | |
| 0.107 | 0.616 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.146 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.515 | 0.048 | Integrin alpha5beta1 antagonist | 0.046 0.021 CHEMBL3527413 0.048 0.019 CHEMBL3526822 | CHEMBL3526822 | |
| 0.015 | 0.527 | 0.2 | Protease inhibitor | 0.132 0.039 CHEMBL3527413 0.2 0.014 CHEMBL3526822 | CHEMBL3526822 | |
| 0.019 | 0.546 | 0.086 | Chymotrypsin inhibitor | 0.078 0.056 CHEMBL3527413 0.08 0.055 CHEMBL3526822 0.086 0.047 CHEMBL610 | CHEMBL610 | |
| 0.022 | 0.558 | 0.063 | Caspase 9 inhibitor | 0.062 0.043 CHEMBL3527413 0.063 0.042 CHEMBL3526822 | CHEMBL3526822 | |
| 0.01 | 0.564 | 0.081 | Nitric oxide donor | 0.081 0.022 CHEMBL3527413 0.078 0.024 CHEMBL3526822 | CHEMBL3527413 | |
| 0.009 | 0.568 | 0.163 | Glutamate receptor antagonist | 0.163 0.043 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.564 | 0.14 | 5 Hydroxytryptamine 7 antagonist | 0.14 0.019 CHEMBL610 | CHEMBL610 | |
| 0.003 | 0.562 | 0.069 | GP IIb/IIIa receptor antagonist | 0.063 0.027 CHEMBL3527413 0.069 0.025 CHEMBL3526822 0.046 0.036 CHEMBL610 | CHEMBL3526822 | |
| 0.005 | 0.575 | 0.057 | Growth hormone secretagogue receptor antagonist | 0.057 0.015 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.59 | 0.043 | VCAM antagonist | 0.038 0.031 CHEMBL3527413 0.043 0.017 CHEMBL3526822 | CHEMBL3526822 | |
| 0.008 | 0.59 | 0.043 | VCAM-1 antagonist | 0.039 0.031 CHEMBL3527413 0.043 0.017 CHEMBL3526822 | CHEMBL3526822 | |
| 0.017 | 0.601 | 0.045 | Parathyroid hormone antagonist | 0.045 0.033 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.616 | 0.094 | Nav1.1 sodium channel blocker | 0.094 0.073 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.61 | 0.044 | Factor VIIa inhibitor | 0.044 0.022 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.618 | 0.159 | Neurotrophic factor | 0.159 0.051 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.626 | 0.112 | Dopamine agonist | 0.112 0.023 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.632 | 0.042 | GHS receptor agonist | 0.042 0.031 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.63 | 0.167 | Protein kinase B gamma inhibitor | 0.167 0.012 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.629 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.649 | 0.406 | Angiogenesis stimulant | 0.406 0.021 CHEMBL3527413 0.371 0.027 CHEMBL3526822 0.187 0.101 CHEMBL610 | CHEMBL3527413 | |
| 0.02 | 0.663 | 0.098 | Toll-Like receptor 4 antagonist | 0.098 0.072 CHEMBL610 | CHEMBL610 | |
| 0.01 | 0.652 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.028 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.653 | 0.361 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.361 0.009 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.651 | 0.097 | Selectin antagonist | 0.096 0.029 CHEMBL3527413 0.097 0.029 CHEMBL3526822 | CHEMBL3526822 | |
| 0.003 | 0.651 | 0.047 | Somatostatin 5 antagonist | 0.047 0.014 CHEMBL610 | CHEMBL610 | |
| 0.033 | 0.681 | 0.226 | Hypoglycemic | 0.226 0.092 CHEMBL3527413 0.161 0.16 CHEMBL610 | CHEMBL3527413 | |
| 0.011 | 0.669 | 0.173 | Protein kinase (CK1) gamma 3 inhibitor | 0.173 0.066 CHEMBL610 | CHEMBL610 | |
| 0.007 | 0.666 | 0.104 | Protein kinase B beta inhibitor | 0.104 0.023 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.666 | 0.135 | Lipase inhibitor | 0.135 0.013 CHEMBL3526822 | CHEMBL3526822 | |
| 0.004 | 0.668 | 0.047 | Integrin antagonist | 0.039 0.031 CHEMBL3527413 0.047 0.028 CHEMBL3526822 | CHEMBL3526822 | |
| 0.004 | 0.67 | 0.197 | Kinesin antagonist | 0.033 0.032 CHEMBL3527413 0.036 0.027 CHEMBL3526822 0.197 0.004 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.67 | 0.197 | Kinesin-like protein 1 inhibitor | 0.033 0.032 CHEMBL3527413 0.036 0.027 CHEMBL3526822 0.197 0.004 CHEMBL610 | CHEMBL610 | |
| 0.011 | 0.678 | 0.091 | Trypsin inhibitor | 0.059 0.052 CHEMBL3526822 0.091 0.022 CHEMBL610 | CHEMBL610 | |
| 0.018 | 0.686 | 0.145 | Nav1.4 sodium channel blocker | 0.111 0.062 CHEMBL3527413 0.115 0.057 CHEMBL3526822 0.145 0.036 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.681 | 0.096 | Glucagon-like peptide 1 agonist | 0.095 0.025 CHEMBL3527413 0.096 0.024 CHEMBL3526822 | CHEMBL3526822 | |
| 0.013 | 0.693 | 0.124 | Bone formation stimulant | 0.121 0.085 CHEMBL3527413 0.124 0.082 CHEMBL3526822 | CHEMBL3526822 | |
| 0.037 | 0.72 | 0.222 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.222 0.076 CHEMBL610 | CHEMBL610 | |
| 0.008 | 0.7 | 0.112 | Lipid peroxidase inhibitor | 0.112 0.102 CHEMBL3527413 | CHEMBL3527413 | |
| 0.004 | 0.696 | 0.042 | Protocollagen prolyl hydroxylase inhibitor | 0.035 0.01 CHEMBL3527413 0.042 0.007 CHEMBL3526822 | CHEMBL3526822 | |
| 0.005 | 0.699 | 0.066 | CXC chemokine receptor antagonist | 0.066 0.055 CHEMBL610 | CHEMBL610 | |
| 0.015 | 0.713 | 0.124 | Insulin secretagoues | 0.12 0.111 CHEMBL3527413 0.124 0.105 CHEMBL3526822 | CHEMBL3526822 | |
| 0.025 | 0.73 | 0.287 | Hematopoietic | 0.257 0.006 CHEMBL3527413 0.287 0.005 CHEMBL3526822 0.092 0.045 CHEMBL610 | CHEMBL3526822 | |
| 0.003 | 0.71 | 0.033 | Factor X inhibitor | 0.033 0.032 CHEMBL610 | CHEMBL610 | |
| 0.027 | 0.738 | 0.305 | Hepatoprotectant | 0.305 0.028 CHEMBL3527413 0.263 0.04 CHEMBL3526822 | CHEMBL3527413 | |
| 0.005 | 0.718 | 0.082 | Protein kinase C epsilon inhibitor | 0.082 0.018 CHEMBL610 | CHEMBL610 | |
| 0.006 | 0.73 | 0.075 | Plasminogen activator inhibitor | 0.075 0.029 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.781 | 0.112 | Transcription factor NF kappa B stimulant | 0.107 0.033 CHEMBL3527413 0.112 0.03 CHEMBL3526822 | CHEMBL3526822 | |
| 0.009 | 0.771 | 0.144 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.144 0.137 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.767 | 0.065 | Acetyl-CoA transferase 1 inhibitor | 0.065 0.008 CHEMBL3526822 | CHEMBL3526822 | |
| 0.015 | 0.781 | 0.083 | Adenine nucleotide translocase inhibitor | 0.08 0.009 CHEMBL3527413 0.083 0.008 CHEMBL3526822 | CHEMBL3526822 | |
| 0.009 | 0.794 | 0.105 | Factor XII inhibitor | 0.101 0.037 CHEMBL3527413 0.105 0.033 CHEMBL3526822 | CHEMBL3526822 | |
| 0.008 | 0.794 | 0.062 | I kappa B kinase 1 inhibitor | 0.062 0.061 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.792 | 0.091 | Acetyl-CoA transferase inhibitor | 0.091 0.016 CHEMBL3526822 | CHEMBL3526822 | |
| 0.007 | 0.798 | 0.117 | Protein kinase (CK1) gamma 1 inhibitor | 0.117 0.101 CHEMBL610 | CHEMBL610 | |
| 0.021 | 0.812 | 0.231 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.231 0.124 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.817 | 0.069 | Protein kinase B alpha inhibitor | 0.069 0.048 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.832 | 0.365 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.365 0.024 CHEMBL610 | CHEMBL610 | |
| 0.013 | 0.844 | 0.279 | Cyclophilin D inhibitor | 0.279 0.182 CHEMBL3527413 | CHEMBL3527413 | |
| 0.004 | 0.841 | 0.145 | Protein kinase A inhibitor | 0.145 0.026 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.844 | 0.046 | Kallikrein inhibitor | 0.046 0.034 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.85 | 0.157 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 CHEMBL3527413 0.102 0.043 CHEMBL3526822 0.157 0.017 CHEMBL610 | CHEMBL610 | |
| 0.023 | 0.892 | 0.752 | NOS3 expression enhancer | 0.752 0.003 CHEMBL2074871 | CHEMBL2074871 | |
| 0.004 | 0.889 | 0.082 | Pim-1 kinase inhibitor | 0.082 0.078 CHEMBL610 | CHEMBL610 | |
| 0.009 | 0.906 | 0.426 | Immunomodulator | 0.27 0.1 CHEMBL3527413 0.426 0.037 CHEMBL3526822 | CHEMBL3526822 | |
| 0.005 | 0.911 | 0.246 | Vasodilator | 0.246 0.071 CHEMBL610 | CHEMBL610 | |
| 0.005 | 0.93 | 0.331 | Thrombolytic | 0.312 0.022 CHEMBL3527413 0.331 0.019 CHEMBL3526822 0.164 0.072 CHEMBL610 | CHEMBL3526822 | |
| 0.004 | 0.941 | 0.096 | Protein kinase C delta inhibitor | 0.096 0.056 CHEMBL610 | CHEMBL610 | |
| 0.004 | 0.942 | 0.057 | Elastase inhibitor | 0.057 0.033 CHEMBL3526822 | CHEMBL3526822 | |
| 0.005 | 0.949 | 0.43 | Interleukin antagonist | 0.417 0.028 CHEMBL3527413 0.43 0.027 CHEMBL3526822 0.257 0.059 CHEMBL610 | CHEMBL3526822 | |
| 0.004 | 0.967 | 0.29 | Platelet antagonist | 0.263 0.067 CHEMBL3527413 0.29 0.056 CHEMBL3526822 0.199 0.101 CHEMBL610 | CHEMBL3526822 | |
| 0.004 | 0.976 | 0.271 | Anticoagulant | 0.193 0.056 CHEMBL3527413 0.271 0.034 CHEMBL3526822 0.205 0.051 CHEMBL610 | CHEMBL3526822 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |